Literature DB >> 22590407

3-Anilinomethyl-5-chloro-1,3--benzoxazol-2(3H)-one.

Abdullah Aydın, Zeynep Soyer, Mehmet Akkurt, Orhan Büyükgüngör.   

Abstract

In the title compound, C(14)H(11)ClN(2)O(2), the 2,3-dihydro-1,3-benzoxazole ring system is essentially planar [maximum deviation = 0.009 (2) Å] and makes a dihedral angle of 79.15 (7)° with the phenyl ring. Inter-molecular N-H⋯O and weak C-H⋯Cl hydrogen bonds occur in the crystal structure.

Entities:  

Year:  2012        PMID: 22590407      PMCID: PMC3344645          DOI: 10.1107/S1600536812017709

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis and biological activity of compounds with a benzoxazolone nucleus, see; Varma & Nobles (1968 ▶); Courtois et al. (2004 ▶); Deng et al. (2006 ▶); Ivanova et al. (2007 ▶); Koksal et al. (2002 ▶, 2005 ▶); Onkol et al. (2001 ▶); Soyer et al. (2005 ▶); Ucar et al. (1998 ▶); Unlu et al. (2003 ▶). For bond-length data, see: Allen et al. (1987 ▶). For a related structure, see: Aydın et al. (2004 ▶).

Experimental

Crystal data

C14H11ClN2O2 M = 274.70 Monoclinic, a = 9.7379 (5) Å b = 12.4797 (7) Å c = 10.2392 (7) Å β = 93.129 (5)° V = 1242.48 (13) Å3 Z = 4 Mo Kα radiation μ = 0.31 mm−1 T = 296 K 0.80 × 0.48 × 0.26 mm

Data collection

Stoe IPDS 2 diffractometer Absorption correction: integration (X-RED32; Stoe & Cie, 2002 ▶) T min = 0.837, T max = 0.924 20574 measured reflections 3051 independent reflections 2544 reflections with I > 2σ(I) R int = 0.046

Refinement

R[F 2 > 2σ(F 2)] = 0.043 wR(F 2) = 0.106 S = 1.07 3051 reflections 172 parameters H-atom parameters constrained Δρmax = 0.22 e Å−3 Δρmin = −0.22 e Å−3 Data collection: X-AREA (Stoe & Cie, 2002 ▶); cell refinement: X-AREA; data reduction: X-RED32 (Stoe & Cie, 2002 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶) and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536812017709/xu5511sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812017709/xu5511Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536812017709/xu5511Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C14H11ClN2O2F(000) = 568
Mr = 274.70Dx = 1.469 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 27572 reflections
a = 9.7379 (5) Åθ = 2.1–28.6°
b = 12.4797 (7) ŵ = 0.31 mm1
c = 10.2392 (7) ÅT = 296 K
β = 93.129 (5)°Prism, colourless
V = 1242.48 (13) Å30.80 × 0.48 × 0.26 mm
Z = 4
Stoe IPDS 2 diffractometer3051 independent reflections
Radiation source: sealed X-ray tube, 12 x 0.4 mm long-fine focus2544 reflections with I > 2σ(I)
Plane graphite monochromatorRint = 0.046
Detector resolution: 6.67 pixels mm-1θmax = 28.2°, θmin = 2.6°
ω scansh = −12→12
Absorption correction: integration (X-RED32; Stoe & Cie, 2002)k = −16→16
Tmin = 0.837, Tmax = 0.924l = −13→13
20574 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.043Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.106H-atom parameters constrained
S = 1.07w = 1/[σ2(Fo2) + (0.0456P)2 + 0.2748P] where P = (Fo2 + 2Fc2)/3
3051 reflections(Δ/σ)max < 0.001
172 parametersΔρmax = 0.22 e Å3
0 restraintsΔρmin = −0.22 e Å3
Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles
Refinement. Refinement on F2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The observed criterion of F2 > σ(F2) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.37199 (5)0.42730 (6)−0.40607 (5)0.0887 (2)
O10.61747 (10)0.34298 (10)0.11087 (11)0.0535 (3)
O20.52561 (13)0.24080 (12)0.26644 (11)0.0679 (4)
N10.41738 (11)0.26396 (10)0.06103 (11)0.0428 (4)
N20.16989 (12)0.24829 (12)0.04683 (12)0.0508 (4)
C10.45104 (13)0.32285 (11)−0.04809 (13)0.0392 (4)
C20.38425 (14)0.33757 (13)−0.16827 (14)0.0454 (4)
C30.45056 (16)0.40463 (14)−0.25277 (15)0.0520 (5)
C40.57449 (16)0.45354 (13)−0.22095 (18)0.0553 (5)
C50.64095 (15)0.43708 (13)−0.09935 (17)0.0539 (5)
C60.57568 (14)0.37153 (12)−0.01549 (15)0.0447 (4)
C70.51813 (15)0.27708 (13)0.15798 (15)0.0495 (5)
C80.29647 (15)0.19414 (13)0.06944 (15)0.0479 (5)
C90.11468 (13)0.31842 (12)0.13447 (13)0.0422 (4)
C100.17189 (15)0.33453 (13)0.26004 (14)0.0475 (4)
C110.10954 (17)0.40404 (15)0.34387 (16)0.0565 (5)
C12−0.00743 (18)0.45947 (15)0.30515 (19)0.0624 (6)
C13−0.06427 (19)0.44406 (16)0.1809 (2)0.0659 (6)
C14−0.00497 (17)0.37461 (15)0.09612 (16)0.0567 (5)
H20.300600.30500−0.191400.0550*
H2A0.124300.23690−0.026100.0610*
H40.614000.49800−0.281400.0660*
H50.725200.46880−0.076100.0650*
H8A0.302100.136800.005900.0580*
H8B0.298600.161800.155700.0580*
H100.252000.298700.287800.0570*
H110.147700.413400.428300.0680*
H12−0.047500.506700.362100.0750*
H13−0.143700.481000.153700.0790*
H14−0.044900.364900.012400.0680*
U11U22U33U12U13U23
Cl10.0635 (3)0.1420 (6)0.0602 (3)0.0059 (3)−0.0005 (2)0.0431 (3)
O10.0397 (5)0.0669 (7)0.0528 (6)−0.0022 (5)−0.0074 (4)−0.0061 (5)
O20.0674 (8)0.0890 (9)0.0457 (6)0.0034 (7)−0.0112 (5)0.0084 (6)
N10.0373 (6)0.0508 (7)0.0399 (6)−0.0004 (5)−0.0007 (4)0.0013 (5)
N20.0387 (6)0.0736 (9)0.0397 (6)−0.0032 (6)−0.0006 (5)−0.0068 (6)
C10.0332 (6)0.0416 (7)0.0429 (7)0.0030 (5)0.0039 (5)−0.0028 (6)
C20.0337 (6)0.0572 (9)0.0452 (7)0.0012 (6)0.0011 (5)0.0028 (6)
C30.0433 (7)0.0645 (10)0.0486 (8)0.0091 (7)0.0050 (6)0.0111 (7)
C40.0468 (8)0.0528 (9)0.0678 (10)0.0010 (7)0.0166 (7)0.0096 (8)
C50.0391 (7)0.0515 (9)0.0716 (10)−0.0055 (6)0.0082 (7)−0.0054 (8)
C60.0353 (6)0.0478 (8)0.0507 (8)0.0027 (6)0.0002 (6)−0.0068 (6)
C70.0431 (7)0.0582 (9)0.0464 (8)0.0066 (7)−0.0044 (6)−0.0024 (7)
C80.0477 (8)0.0487 (8)0.0476 (8)−0.0050 (6)0.0049 (6)0.0000 (6)
C90.0365 (6)0.0503 (8)0.0400 (7)−0.0100 (6)0.0033 (5)0.0036 (6)
C100.0385 (7)0.0609 (9)0.0427 (7)−0.0069 (6)−0.0008 (5)0.0020 (7)
C110.0523 (9)0.0708 (11)0.0463 (8)−0.0130 (8)0.0010 (6)−0.0104 (8)
C120.0565 (9)0.0612 (10)0.0704 (11)−0.0046 (8)0.0110 (8)−0.0156 (9)
C130.0523 (9)0.0667 (11)0.0778 (12)0.0099 (8)−0.0039 (8)−0.0028 (9)
C140.0493 (8)0.0695 (11)0.0501 (8)0.0016 (7)−0.0081 (7)0.0007 (8)
Cl1—C31.7315 (16)C9—C141.398 (2)
O1—C61.3817 (19)C9—C101.388 (2)
O1—C71.3769 (19)C10—C111.384 (2)
O2—C71.198 (2)C11—C121.373 (2)
N1—C11.3914 (18)C12—C131.373 (3)
N1—C71.3669 (19)C13—C141.376 (3)
N1—C81.4711 (19)C2—H20.9300
N2—C81.414 (2)C4—H40.9300
N2—C91.3831 (19)C5—H50.9300
N2—H2A0.8600C8—H8A0.9700
C1—C21.3725 (19)C8—H8B0.9700
C1—C61.3818 (19)C10—H100.9300
C2—C31.388 (2)C11—H110.9300
C3—C41.376 (2)C12—H120.9300
C4—C51.387 (2)C13—H130.9300
C5—C61.368 (2)C14—H140.9300
C6—O1—C7107.78 (11)C9—C10—C11119.87 (14)
C1—N1—C7109.19 (11)C10—C11—C12121.47 (16)
C1—N1—C8125.75 (11)C11—C12—C13118.90 (17)
C7—N1—C8124.99 (12)C12—C13—C14120.73 (17)
C8—N2—C9124.23 (12)C9—C14—C13120.73 (15)
C9—N2—H2A118.00C1—C2—H2122.00
C8—N2—H2A118.00C3—C2—H2122.00
N1—C1—C6106.29 (12)C3—C4—H4120.00
N1—C1—C2132.05 (12)C5—C4—H4120.00
C2—C1—C6121.65 (13)C4—C5—H5122.00
C1—C2—C3115.20 (13)C6—C5—H5122.00
Cl1—C3—C4118.73 (13)N1—C8—H8A109.00
Cl1—C3—C2117.77 (12)N1—C8—H8B109.00
C2—C3—C4123.49 (15)N2—C8—H8A109.00
C3—C4—C5120.48 (15)N2—C8—H8B109.00
C4—C5—C6116.25 (14)H8A—C8—H8B108.00
C1—C6—C5122.93 (14)C9—C10—H10120.00
O1—C6—C5128.24 (13)C11—C10—H10120.00
O1—C6—C1108.83 (12)C10—C11—H11119.00
O1—C7—N1107.90 (12)C12—C11—H11119.00
O1—C7—O2122.84 (14)C11—C12—H12121.00
O2—C7—N1129.27 (15)C13—C12—H12121.00
N1—C8—N2113.63 (13)C12—C13—H13120.00
N2—C9—C10122.83 (13)C14—C13—H13120.00
C10—C9—C14118.29 (14)C9—C14—H14120.00
N2—C9—C14118.87 (13)C13—C14—H14120.00
C7—O1—C6—C5179.00 (16)N1—C1—C2—C3179.08 (15)
C6—O1—C7—O2−178.94 (16)C6—C1—C2—C3−0.3 (2)
C7—O1—C6—C1−0.57 (16)N1—C1—C6—O10.04 (16)
C6—O1—C7—N10.88 (16)C2—C1—C6—C50.0 (2)
C7—N1—C1—C2−178.96 (16)C1—C2—C3—Cl1−179.79 (12)
C8—N1—C1—C23.9 (2)C1—C2—C3—C40.2 (2)
C1—N1—C7—O1−0.86 (16)C2—C3—C4—C50.3 (3)
C8—N1—C7—O1176.31 (13)Cl1—C3—C4—C5−179.75 (13)
C1—N1—C7—O2178.93 (17)C3—C4—C5—C6−0.6 (2)
C8—N1—C7—O2−3.9 (3)C4—C5—C6—C10.5 (2)
C1—N1—C8—N2−59.57 (18)C4—C5—C6—O1−179.03 (15)
C7—N1—C8—N2123.72 (15)N2—C9—C10—C11−178.47 (15)
C8—N1—C1—C6−176.64 (13)C14—C9—C10—C110.6 (2)
C7—N1—C1—C60.51 (16)N2—C9—C14—C13179.13 (16)
C8—N2—C9—C10−6.8 (2)C10—C9—C14—C130.0 (2)
C9—N2—C8—N1−72.99 (18)C9—C10—C11—C12−1.1 (3)
C8—N2—C9—C14174.17 (15)C10—C11—C12—C130.9 (3)
C2—C1—C6—O1179.57 (13)C11—C12—C13—C14−0.3 (3)
N1—C1—C6—C5−179.55 (14)C12—C13—C14—C9−0.2 (3)
D—H···AD—HH···AD···AD—H···A
N2—H2A···O2i0.862.303.1296 (17)162
C11—H11···Cl1ii0.932.703.5295 (17)150
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H2A⋯O2i0.862.303.1296 (17)162
C11—H11⋯Cl1ii0.932.703.5295 (17)150

Symmetry codes: (i) ; (ii) .

  12 in total

1.  Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings.

Authors:  Bo-Liang Deng; Matthew D Cullen; Zhigang Zhou; Tracy L Hartman; Robert W Buckheit; Christophe Pannecouque; Erik De Clercq; Phillip E Fanwick; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2006-04-01       Impact factor: 3.641

2.  Synthesis and antibacterial activity of certain 3-substituted benzoxazolinones.

Authors:  R S Varma; W L Nobles
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

3.  Synthesis of some 2(3H)-benzoxazolone derivatives and their in-vitro effects on human leukocyte myeloperoxidase activity.

Authors:  Zeynep Soyer; Meral Bas; Aysun Pabuccuoglu; Varol Pabuccuoglu
Journal:  Arch Pharm (Weinheim)       Date:  2005-09       Impact factor: 3.751

4.  Synthesis and biological evaluation with plant cells of new fosmidomycin analogues containing a benzoxazolone or oxazolopyridinone ring.

Authors:  Martine Courtois; Zoia Mincheva; Françoise Andreu; Marc Rideau; Marie-Claude Viaud-Massuard
Journal:  J Enzyme Inhib Med Chem       Date:  2004-12       Impact factor: 5.051

5.  Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives.

Authors:  H Ucar; K Van derpoorten; S Cacciaguerra; S Spampinato; J P Stables; P Depovere; M Isa; B Masereel; J Delarge; J H Poupaert
Journal:  J Med Chem       Date:  1998-03-26       Impact factor: 7.446

6.  Synthesis and antinociceptive activity of (2-benzazolon-3-yl)propionamide derivatives.

Authors:  T Onkol; S Ito; E Yildirim; K Erol; M F Sahin
Journal:  Arch Pharm (Weinheim)       Date:  2001-01       Impact factor: 3.751

7.  Synthesis of 3-(4-substituted benzoylmethyl)-2-benzoxazolinones and screening antimicrobial activities.

Authors:  Meriç Köksal; Nesrin Gökhan; Hakki Erdoğan; Meral Ozalp; Melike Ekizoğlu
Journal:  Farmaco       Date:  2002-07

8.  Synthesis, analgesic and antiinflammatory properties of certain 5-/6-acyl-3-(4-substituted-1-piperazinylmethyl)-2-benzoxazolinones derivatives.

Authors:  Meriç Köksal; Nesrin Gökhan; Esra Küpeli; Erdem Yesilada; Hakki Erdoğan
Journal:  Arch Pharm (Weinheim)       Date:  2005-03       Impact factor: 3.751

9.  Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones.

Authors:  Y Ivanova; G Momekov; O Petrov; M Karaivanova; V Kalcheva
Journal:  Eur J Med Chem       Date:  2007-03-12       Impact factor: 6.514

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more
  2 in total

1.  Crystal structure and theoretical study of N,N-bis-[(5-chloro-2-oxo-2,3-di-hydro-benzo[d]oxazol-3-yl)meth-yl]-2-phenyl-ethanamine.

Authors:  Abdullah Aydın; Zeynep Soyer; Mehmet Akkurt; Orhan Büyükgüngör
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-04-27

2.  3-({4-[(2-Methyl-benzyl-idene)amino]-5-sulfanyl-idene-1H-1,2,4-triazol-3-yl}meth-yl)-1,3-benzoxazol-2(3H)-one.

Authors:  Abdullah Aydın; Nuray Hekimoğlu; Mehmet Akkurt; Tijen Onkol; Sölen Urlu Ciçekli; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.